Sotyktu (deucravacitinib)

pCPA File Number: 22432

Negotiation Status:

Under consideration for negotiation

Indication(s):

Psoriasis, moderate to severe plaque

Sponsor/Manufacturer:

Bristol-Myers Squibb Company

CADTH Project Number:

SR0756-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable